Most of the inhouse bickering was about whether to focus on commercializing ilumen for revenue or to keep pouring money into FDA.
They have decided to focus on commercializing ilumen and we will see revenue soon in the new year. Isn't that what ASH wants?
They are so so close to sealing contracts I can almost taste it. Compass deals could see a 3 bagger alone. Wasn't a bad read to me. IMO.
Most of the inhouse bickering was about whether to focus on...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $8.683M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $57.01K | 3.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 450000 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 203847 | 2 |
View Market Depth
| Last trade - 15.21pm 04/10/2024 (20 minute delay) ? |
| TRI (ASX) Chart |